In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Atea Pharmaceuticals Inc (NASDAQ: AVIR) closed at $3.13 in the last session, down -0.95% from day before closing price of $3.16. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 1.38 million shares were traded. AVIR stock price reached its highest trading level at $3.23 during the session, while it also had its lowest trading level at $3.1.
Ratios:
We take a closer look at AVIR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 19.33 and its Current Ratio is at 19.33. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on August 13, 2024, Upgraded its rating to Equal-Weight and sets its target price to $6.88 from $2 previously.
Morgan Stanley Downgraded its Equal-Weight to Underweight on January 06, 2022, whereas the target price for the stock was revised from $14 to $7.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 10 ’24 when BERGER FRANKLIN M sold 359,606 shares for $2.85 per share. The transaction valued at 1,023,475 led to the insider holds 451,897 shares of the business.
Franklin Berger bought 359,606 shares of AVIR for $1,023,475 on Dec 10 ’24. On Sep 17 ’24, another insider, Sommadossi Jean-Pierre, who serves as the President, CEO, and Chairman of the company, sold 33,941 shares for $4.05 each. As a result, the insider received 137,318 and left with 5,890,053 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVIR now has a Market Capitalization of 264369520 and an Enterprise Value of -216608624.
Stock Price History:
Over the past 52 weeks, AVIR has reached a high of $4.60, while it has fallen to a 52-week low of $2.75. The 50-Day Moving Average of the stock is -5.71%, while the 200-Day Moving Average is calculated to be -13.09%.
Shares Statistics:
According to the various share statistics, AVIR traded on average about 240.49K shares per day over the past 3-months and 541430 shares per day over the past 10 days. A total of 84.46M shares are outstanding, with a floating share count of 74.01M. Insiders hold about 12.38% of the company’s shares, while institutions hold 66.02% stake in the company. Shares short for AVIR as of 1732838400 were 2608626 with a Short Ratio of 10.85, compared to 1730332800 on 2590497. Therefore, it implies a Short% of Shares Outstanding of 2608626 and a Short% of Float of 4.34.
